CARGO Therapeutics 8-K Filing Report: Key Insights from February 24, 2025

Here are the key insights extracted from the provided section of the financial report for CARGO Therapeutics, Inc.:

1. Filing Information:

• Filing Type: 8-K
• Filing Date: February 24, 2025

2. Entity Details:

• Company Name: CARGO Therapeutics, Inc.
• CIK (Central Index Key): 0001966494
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-41859
• EIN (Employer Identification Number): 84-4080422

3. Address:

• Location: 835 Industrial Road, Suite 400, San Carlos, CA 94070
• Phone Number: (650) 499-8950

4. Securities Information:

• Common Stock: Par value of $0.001 per share
• Ticker Symbol: CRGX
• Exchange: NASDAQ

5. Report Period:

• Duration: The report covers a specific date of February 24, 2025.

Summary:

This report indicates that CARGO Therapeutics, Inc. filed an 8-K on February 24, 2025, which is a current report used to disclose important events that shareholders should know about. The company is incorporated in Delaware, operates under the ticker CRGX on NASDAQ, and has a par value of $0.001 for its common stock. The report is tied to a precise date, suggesting it may pertain to a specific event or announcement on that day.